![Liren Tang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liren Tang
Vorstandsvorsitzender bei Welichem Biotech, Inc.
Aktive Positionen von Liren Tang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Vorstandsvorsitzender | 18.11.2009 | - |
Präsident | 18.11.2009 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 17.11.2009 | 18.11.2009 |
Karriereverlauf von Liren Tang
Ehemalige bekannte Positionen von Liren Tang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vancouver Coastal Health Research Institute
![]() Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Liren Tang
University of British Columbia | Doctorate Degree |
Statistik
International
Kanada | 4 |
Operativ
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Welichem Biotech, Inc.
![]() Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Vancouver Coastal Health Research Institute
![]() Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Commercial Services |
- Börse
- Insiders
- Liren Tang
- Erfahrung